Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Insulin × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Breast 1

Conditions

Insulin Resistance 1 Breast Neoplasms 1

Interventions

Trastuzumab 610 Paclitaxel 573 Cyclophosphamide 545 Docetaxel 484 Capecitabine 425 Letrozole 362 Fulvestrant 328 Carboplatin 324 Doxorubicin 285 Tamoxifen 259 Anastrozole 228 pembrolizumab 225 Radiotherapy 213 exemestane 212 Epirubicin 204 Bevacizumab 188 pertuzumab 187 palbociclib 176 Gemcitabine 175 Vinorelbine 169 Lapatinib 160 Magnetic Resonance Spectroscopy 147 130-nm albumin-bound paclitaxel 142 eribulin 132 Surveys and Questionnaires 130 Albumin-Bound Paclitaxel 129 Exercise 124 Fluorouracil 113 Drug Therapy 110 Blood Specimen Collection 107

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05010356 2021-08-18

Insulin Sensitivity After Breast Cancer

University of Copenhagen

Phase NA Recruiting

Breast Neoplasms, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡